A first-in-human, pharmacokinetic and tolerability study of LFF 571 at single and multiple doses in volunteers.

Trial Profile

A first-in-human, pharmacokinetic and tolerability study of LFF 571 at single and multiple doses in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Sep 2012

At a glance

  • Drugs LFF 571 (Primary)
  • Indications Clostridium infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Sep 2011 New trial record
    • 20 Sep 2011 Results presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top